Alternative routes of mucosal immunization in large animals

Immunology and Cell Biology

Volumn 82, Issue 1, 2004, Pages 10-16

  Sedgmen, Bradley J ^a,b   Meeusen, Els N T ^a   Lofthouse, Shari A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Immunization; Intranasal; Intrarectal; Livestock; Mucosal

Indexed keywords

ADJUVANT; ALGINIC ACID; CHITOSAN; DNA VACCINE; IMMUNOGLOBULIN A; ISCOM; LIPOSOME; MICROSPHERE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; BOVIDS; BOVINE HERPES VIRUS; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HAEMONCHUS CONTORTUS; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; INTESTINE LYMPHATIC TISSUE; MUCOSAL IMMUNITY; NONHUMAN; NOSE MUCOSA; PEYER PATCH; PLASMA CELL; RECTUM MUCOSA; REVIEW; STOMACH MUCOSA; TRANSMISSION ELECTRON MICROSCOPY; VIBRIO CHOLERAE;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, RECTAL; ANIMALS; ANTIGENS; IMMUNITY, MUCOSAL; IMMUNIZATION; MUCOUS MEMBRANE;

ANIMALIA; BOS TAURUS; BOVIDAE; BOVINAE; ESCHERICHIA COLI; HAEMONCHUS CONTORTUS; HERPESVIRIDAE; OVIS ARIES; VIBRIO; VIBRIO CHOLERAE;

EID: 1642408438     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1711.2004.01214.x     Document Type: Review

References (76)

1. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 1987; 7: 265-76.
2. McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992; 10: 75-88.
3. Mestecky J, Michalek SM, Moldoveanu Z, Russell MW. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans. Behring Inst. Mitt. 1997: 98: 33-43.
4. Haneberg B, Kendall D, Amerongen HM, Apter FM, Kraehenbuhl J-P, Neutra MR. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions for local mucosal surfaces. Infect. Immun. 1994; 62: 15-23.
5. Lehner T, Wang Y, Ping L et al. The effect of route of immunization on mucosal immunity and protection. J. Infect. Dis. 1999; 179: S489-92.
6. Gilligan CA, Li Wan Po A. Oral vaccines: design and delivery. Int. J. Pharm. 1991; 75: 1-24.
7. Medina E, Guzman CA. Modulation of immune responses following antigen administration by mucosal route. FEMS Immunol. Med. Microbiol. 2000; 27: 305-11.
8. Simecka J. Mucosal immunity of the gastrointestinal tract and oral tolerance. Adv. Drug Deliv. Rev. 1998; 34: 235-59.
9. Hein WR, Griebel PJ. A road less traveled: large animal models in immunological research. Nat. Rev. Immunol. 2003; 3: 79-84.
10. Gerdts V, Snider M, Brownlie R, Babuik LA, Griebel PJ. Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate. J. Immunol. 2002; 168: 1877-85.
11. Coulter A, Harris R, Davis R et al. Intranasal vaccination with ISCOMATRIX (R.) adjuvanted influenza vaccine. Vaccine 2003; 21: 946-9.
12. Loehr BI, Wilson P, Babiuk LA, van Drunen Littel-van den Hurk S. Gene gun-mediated DNA immunization primes development of mucosal immunity against bovine herpes virus 1 in cattle. J. Virol. 2000; 74: 6077-86.
13. Loehr BI, Rankin R, Pontarollo R et al. Suppository-mediated DNA immunization induces mucosal immunity against bovine herpes virus-1 in cattle. Virology 2001; 289: 327-33.
14. Bowersock TL, HogenEsch T, Suckow M et al. Oral vaccination of animals with antigens encapsulated in alginate microspheres. Vaccine 1999; 26: 1804-11.
15. Vassilev VB, Gil LH, Bonis RO. Microparticle-mediated RNA immunization against bovine viral diarrhoea virus. Vaccine 2001; 19: 2012-9.
16. Shimoji Y, Oishi E, Kitajima T, Muneta Y, Shimizu S, Mori Y. Erysipelothrix rhusiopathiae YS-1 as a live vaccine vehicle for heterologous protein expression and intranasal immunization of pigs. Infect. Immun. 2002; 70: 226-32.
17. Felder CB, Vorlaender N, Gander B, Merkle HP, Bertschinger HU. Microencapsulated enterotoxigenic Escherichia coli and detached fimbriae for peroral vaccination of pigs. Vaccine 2000; 19: 706-15.
18. Reynolds J. The genesis, tutelage and exodus of B cells in the ileal Peyer's patch of sheep. Int. Rev. Immunol. 1997; 15: 265-99.
19. Mutwiri G, Watts T, Lew L et al. Ileal and jejunal Peyer's patches play distinct roles in mucosal immunity of sheep. Immunology 1999; 97: 455-61.
20. Pabst R, Reynolds JD. Peyer's patches export lymphocytes throughout the lymphoid system in sheep. J. Immunol. 1987; 139: 3981-5.
21. Teichmann U, Liebler-Tenorio EM, Pohlenz JF. Ultrastructural changes in follicles of small-intestinal aggregated lymphoid nodules in early and advanced phases of experimentally induced mucosal diseases in calves. Am. J. Vet. Res. 2000; 61: 174-82.
22. Nagi AM, Babiuk LA. Characterization of surface markers of bovine gut mucosal leukocytes using monoclonal antibodies. Vet. Immunol. Immunopathol. 1989; 22: 1-14.
23. Liebler EM, Press C, Landsverk T. Lymphocyte subpopulations in jejunal and ileal Peyer's patches of calves with experimental Salmonella dublin infection. J. Vet. Med. 1994; 41: 113-25.
24. Bianchi ATJ, Zwart RJ, Jeurissen SHM, Moonen-Leusen HWM. Development of the B-and T-cell compartments in porcine lymphoid organs from birth to adult life: an immunohistological approach. Vet. Immunol. Immunopathol. 1992; 33: 201-21.
25. Solano-Aguilar GI, Vengroski KG, Beshah E, Lunney JK. Isolation and purification of lymphocyte subsets from gut-associated lymphoid tissue in neonatal swine. J. Immunol. Meth. 2000; 241: 185-99.
26. Azim T. Lymphocytes in the intestine: role and distribution. J. Diarrhoeal Dis. Res. 1991; 9: 1-10.
27. Neutra MR, Mantis NJ, Frey A, Giannasca PJ. The composition and function of M cell apical membranes: implications for microbial pathogenesis. Semin. Immunol. 1999; 11: 171-81.
28. Sedgmen BJ, Lofthouse SA, Scheerlinck J-PY, Meeusen ENT. Cellular and molecular characterisation of the ovine rectal mucosal environment. Vet. Immunol. Immunopathol. 2002; 86: 215-20.
29. Liebler EM, Pohlenza JF, Woode GN. Gut-associated lymphoid tissue in the large intestine of calves. I. Distribution and histology. Vet. Pathol. 1988; 25: 503-8.
30. Morfitt DC, Pohlenz JFL. Porcine colonie lymphoglandular complexes: distribution, structure and epithelium. Am. J. Anat. 1989; 184: 41-51.
31. Langman JM, Rowland R. The number and distribution of lymphoid follicles in the human large intestine. J. Anat. 1986; 194: 189-94.
32. Liebler EM, Paar M, Pohlenz JF. M cells in the rectums of calves. Res. Vet. Sci. 1991; 51: 107-11.
33. Liebler EM, Lemke C, Pohlenz JF. Ultrastructural study of the uptake of ferritin by M cells in the follicle-associated epithelium in the small intestines of pigs. Am. J. Vet. Res. 1995; 56; 725-30.
34. Stanley AC, Huntley JF, Jeffrey M, Buxton D. Characterization of ovine nasal-associated lymphoid tissue and identification of M cells in the overlying follicle-associated epithelium. J. Comp. Pathol. 2001; 125: 262-70.
35. Fujimura Y. Evidence of M cells as portals of entry for antigens in the nasopharyngeal lymphoid tissue of humans. Virchows Arch. 2000; 436: 560-6.
36. Crowley-Nowick PA, Bell MC, Brockwell R et al. Rectal immunization for induction of specific antibody in the genital tract of women. J. Clin. Immunol. 1997; 17: 370-9.
37. Kozlowski PA, Cu-Uvin S, Neutra MR, Flanigan TP. Mucosal vaccination strategies for women. J. Infect. Dis. 1999; 179: S493-8.
38. Kantele A, Hakkinen M, Moldoveanu Z et al. Differences in immune responses induced by oral and rectal immunizations with Salmonella typhi Ty21a: evidence for compartmentalization within the common mucosal immune system in humans. Infect. Immun. 1998; 66: 5630-5.
39. Forrest BD, Shearman DJC, LaBrooy JT. Specific immune response in humans following rectal delivery of live typhoid vaccine. Vaccine 1990; 8: 209-12.
40. Rudin A, Riise GC, Holmgren J. Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit. Infect. Immun. 1999; 67: 2884-90.
41. Ogra PL, Karzon DT. Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with polio vaccine. J. Immunol. 1969; 102: 1423-30.
42. Jacobs HJ, Ashman K, Meeusen E. Vaccination against the gastrointestinal nematode, Haemonchus contortus, using a purified larval surface antigen. Vaccine 1999; 17: 362-8.
43. Rebelatto MC, Siger L, Hogenesch H. Kinetics and type of immune response following intranasal and subcutaneous immunisation of calves. Vet. Res. Sci. 2001; 71: 9-15.
44. Husband AJ, Bao S, McClure SJ, Emery DL, Ramsay AJ. Antigen delivery strategies for mucosal vaccines. Int. J. Parasitol. 1996; 26: 825-34.
45. Ryan EJ, Daly LM, Mills KHG. Immunomodulators and delivery systems for vaccination by mucosal routes. Trends Biotechnol. 2001; 19: 293-304.
46. Cripps AW, Kyd JM, Foxwell AR. Vaccines and mucosal immunisation. Vaccine 2001; 19: 2513-5.
47. Eriksson K, Holmgren J. Recent advances in mucosal vaccines and adjuvants. Curr. Opin. Immunol. 2002; 14: 666-72.
48. Dietrich G, Griot-Wenk M, Metcalfe IC, Lang AB, Viret JF. Experience with registered mucosal vaccines. Vaccine 2003; 21: 678-83.
49. Fooks AR. Development of oral vaccines for human use. Curr. Opin. Mol. Ther. 2000; 2: 80-6.
50. Akiyama Y, Nagahara N, Kashihara T, Hirai S, Toguchi H. In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acids and a poly (acrylic acid) derivative. Pharm. Res. 1995; 12: 397-405.
51. Akiyama Y, Nagahara N, Nara E et al. Evaluation of oral mucosadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites. J. Pharm. Pharmacol. 1998; 50: 159-66.
52. Kunisawa J, Okudaira A, Tsutusmi Y et al. Characterization of mucoadhesive microspheres for the induction of mucosal and systemic immune responses. Vaccine 2000; 19: 589-94.
53. Rebelatto MC, Guimond P, Bowersock TL, HogenEsch H. Induction of systemic and mucosal immune response in cattle by intranasal administration of pig serum albumin in alginate microspheres. Vet. Immunol. Immunopathol. 2001; 83: 93-105.
54. Mutwiri G, Bowersock T, Kidane A et al. Induction of mucosal immune responses following enteric immunization with antigen delivered in alginate microspheres. Vet. Immunol. Immunopathol. 2002; 87: 269-76.
55. Bowersock TL, Martin S. Vaccine delivery to animals. Adv. Drug Deliv. Rev. 1999; 38: 167-94.
56. Bowersock TL, Shalaby WSW, Levy M et al. The potential use of poly (methacrylic acid) hydrogels for oral administration of drugs and vaccines to ruminants. J. Control Release 1994; 31: 245-54.
57. van Drunen Little-van den Hurk S, Gerdts V, Loehr BI et al. Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals. Adv. Drug Deliv. Rev. 2000; 43: 13-28.
58. Babiuk LA, Pontarollo R, Babiuk S, Loehr B, van Drunen Little-van den Hurk S. Induction of immune responses by DNA vaccines in large animals. Vaccine 2003; 21: 649-58.
59. Beard CW, Mason PW. Out on the farm with DNA vaccines. Nat. Biotechnol. 1998; 16: 1325-8.
60. Forrest BD. Effects of sample processing on the measurements of specific intestinal IgA immune responses. Vaccine 1992; 10: 802-5.
61. Challacombe SJ. Assessing mucosal humoral immunity. Clin. Exp. Immunol. 1995; 10: 181-2.
62. Ferguson A, Humphreys KA, Croft NM. Technical report: results of immunological tests on faecal extracts are likely to be extremely misleading. Clin. Exp. Immunol. 1995; 99: 70-5.
63. Gleeson M, Francis JL, Lugg DJ et al. One year in Antarctica: mucosal immunity at three Australian stations. Immunol. Cell Biol. 2000; 78: 616-22.
64. Gerdts V, Uwiera RRE, Mutwiri GK et al. Multiple intestinal 'loops' provide an in vivo model to analyse mucosal immune responses. J. Immunol. Meth. 2001; 256: 19-33.
65. Forrest BD. Indirect measurements of intestinal immune responses to an orally administered attenuated bacterial vaccine. Infect. Immun. 1992; 60: 2023-9.
66. Jungersen G, Eriksen L, Roepstorff A et al. Experimental Ascaris suum infection in the pig: protective memory responses after three immunizations and effect of intestinal adult worm population. Parasite Immunol. 1999; 21: 619-30.
67. Jacobs HJ, Ashman K, Meeusen E. Humoral and cellular responses following local immunization with a surface antigen of the gastrointestinal parasite Haemonchus contortus. Vet. Immunol. Immunopathol. 1995; 48: 323-32.
68. Premier RR, Jacobs HJ, Lofthouse SA, Sedgmen BJ, Meeusen E. Antibody isotype profiles in serum and circulating antibody-secreting cells following mucosal and peripheral immunisations of sheep. Vet. Immunol. Immunopathol. 2003 (in press).
69. Sedgmen BJ, Lofthouse SA, Meeusen ENT. Optimization of an ovine antibody-secreting cell assay for detection of antigen-specific immunoglobulin production in peripheral blood leukocytes. Immunol. Cell. Biol. 2003; 81: 305-10.
70. Kantele A, Takanen R, Arvilommi H. Immune responses to acute diarrhoea seen as circulating antibody-secreting cells. J. Infect. Dis. 1988; 158: 1011-6.
71. Kantele A. Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine. Vaccine 1990; 8: 321-6.
72. Kantele A, Papunen R, Virtanen E et al. Antibody-secreting cells in acute urinary tract infection as indicators of local immune responses. J. Infect. Dis. 1994; 169: 1023-8.
73. Kantele A. Peripheral blood antibody-secreting cells in the evaluation of the immune response to an oral vaccine. J. Biotechnol. 1996; 44: 217-24.
74. Qadri F, Ryan ET, Faruque AS et al. Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers. Infect. Immun 2003; 71: 4808-14.
75. Forrest BD. Identification of an intestinal immune response using peripheral blood lymphocytes. Lancet 1988; 1: 81-3.
76. Jehuda-Cohen T, Slade BA, Powell JD et al. Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals. Proc. Natl Acad. Sci. USA 1990; 87: 3972-6.